Published in PLoS One on December 08, 2014
Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol (2015) 1.57
Physical Function, Hyperuricemia, and Gout in Older Adults. Arthritis Care Res (Hoboken) (2015) 0.77
The association between thyroid disorders and incident gout: population-based case-control study. Clin Epidemiol (2017) 0.75
Increase in thyroid stimulating hormone levels in patients with gout treated with inhibitors of xanthine oxidoreductase. Rheumatol Int (2015) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum (1977) 8.55
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Pathogenesis of gout. Ann Intern Med (2005) 4.50
Independent impact of gout on mortality and risk for coronary heart disease. Circulation (2007) 3.39
Gout and the risk of acute myocardial infarction. Arthritis Rheum (2006) 2.96
Epidemiology of gout: is the incidence rising? J Rheumatol (2002) 2.80
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med (2005) 2.80
Some observations on 520 gouty patients. J Chronic Dis (1955) 2.50
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ (2012) 2.39
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis (2014) 2.36
Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol (1988) 2.32
Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med (2008) 2.32
Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) (2009) 2.08
Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol (2005) 1.76
Cyclosporine-induced hyperuricemia and gout. N Engl J Med (1989) 1.67
Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol (2010) 1.64
Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc (2006) 1.60
The renal manifestations of thyroid disease. J Am Soc Nephrol (2011) 1.46
Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease. Am J Med (1982) 1.30
Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol (2001) 1.29
Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant (2007) 1.29
Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol (2005) 1.28
Correlation of creatinine with TSH levels in overt hypothyroidism - a requirement for monitoring of renal function in hypothyroid patients? Clin Biochem (2011) 1.11
Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol (2002) 1.00
Hypothyroidism and renal impairment. J R Soc Med (1991) 0.99
Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol (2010) 0.89
The prevalence of hypothyroidism in gout. Am J Med (1994) 0.89
Tophaceous gout and chronic kidney disease. J Clin Rheumatol (2007) 0.85
Renal impairment in hypothyroidism. Nephrol Dial Transplant (1994) 0.83
Letter: Gout and hypothyroidism in males. Arthritis Rheum (1976) 0.81
Hyperuricemia in patients with hyperthyroidism due to Graves' disease. Metabolism (1995) 0.81
Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism. Clin Nephrol (1998) 0.80
Serum uric acid concentration and thyroid-stimulating-hormone (TSH): results of screening for hyperuricaemia in 2359 consecutive patients with various degrees of thyroid dysfunction. Wien Klin Wochenschr (1999) 0.77
Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan. Ann Rheum Dis (2013) 0.81
Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families. Arthritis Res Ther (2016) 0.75
Familial aggregation of nasopharyngeal carcinoma in Taiwan. Oral Oncol (2017) 0.75
Familial Aggregation of Head and Neck Cancer in Taiwan. Laryngoscope (2020) 0.75
Familial aggregation of rheumatoid arthritis and co-aggregation of autoimmune diseases in affected families: a nationwide population-based study. Rheumatology (Oxford) (2017) 0.75
Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis. Oncotarget (2017) 0.75
Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study. JAMA Cardiol (2017) 0.75
Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis. Oncotarget (2017) 0.75